共 24 条
[1]
Folkman J., What is the evidence that tumors are angiogenesis dependent?, J Natl Cancer Inst, 82, pp. 4-6, (1990)
[2]
Folkman J., Angiogenesis in cancer, vascular, rheumatoid and other disease, Nat Med, 1, pp. 27-31, (1995)
[3]
Folkman J., Shing Y., Angiogenesis, J Biol Chem, 267, pp. 10931-10934, (1992)
[4]
Moore R., Casey G., Brookes S., Dixon M., Peters G., Dickson C., Sequence, topography and protein coding potential of mouse int-2: A putative oncogene activated by mouse mammary tumour virus, EMBO J, 5, pp. 919-924, (1986)
[5]
Taira M., Yoshida T., Miyagawa K., Sakamoto H., Terada M., Sugimura T., cDNA sequence of human transforming gene hst and identification of the coding sequence required for transforming activity, Proc Natl Acad Sci USA, 84, pp. 2980-2984, (1987)
[6]
Hughes S., Hall P., The fibroblast growth factor and receptor multigene families, J Pathol, 170, pp. 219-221, (1993)
[7]
Shibuya M., Role of VEGF-flt receptor system in normal and tumor angiogenesis, Adv Cancer Res, 67, pp. 281-316, (1995)
[8]
Houck K.A., Ferrara N., Winer J., Cachianes G., Li B., Leung D.W., The vascular endothelial growth factor family: Identification of a fourth molecular species and characterization of alternative splicing of RNA, Mol Endocrinol, 5, pp. 1806-1814, (1991)
[9]
Houck K.A., Leung D.W., Rowland A.M., Winer J., Ferrara N., Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms, J Biol Chem, 267, pp. 26031-26037, (1992)
[10]
Hori A., Sasada R., Matsutani E., Et al., Suppression of solid tumor growth by immunoneutralizing monoclonal antibody against human basic fibroblast growth factor, Cancer Res, 51, pp. 6180-6184, (1991)